2m 2m 2m 2m 2m 2m 2m
Paradigm Biopha (PBIGF)
OTC
$0.01+$0.01 (+643.75%)
Price as of Oct 22, 2026- N/AMarket Cap
- -96.10%1-Year Change
- BiotechnologyIndustry
Paradigm Biopha (PBIGF)
$0.01+$0.01 (+643.75%)
Key Performance
More- Earnings Score: N/A
- Momentum Score: N/A
- True Yield: N/A
- Financial Health Score: N/A
Latest Research & News
No data found
Peers
Statistics
MoreDay Range
$0.01
$0.01
$0.01
1-Year Range
$0.001
$0.32
$0.01
Latest Close$0.01
Change
+$0.01 (+86.55%)
Volume17,600
Information as of 10/22/2026
Company Profile
PARADIGM BIOPHARMACEUTICL
N/A
Market Cap
N/A
Net Income
Sector: Healthcare
Industry: Biotechnology
PARADIGM BIOPHARMACEUTICL
Key Executives
- Paul John Rennie MSTC
- Donna L. Skerrett
- Beverley Huttmann
- Abby Macnish Niven
- Simon White
Current Ownership Distribution
- Other626.4M (100.00%)
- Institutions0 (0.00%)
- Mutual Funds0 (0.00%)
- Insiders0 (0.00%)